Name: Cytokinetics Inc. (NASDAQ:CYTK) | Balance Sheet: Assets
Creator: Stock Analysis on Net

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Cytokinetics Inc., consolidated balance sheet: assets

US$ in thousands

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash and cash equivalents	65,582)	112,666)	82,985)	36,433)	42,256)
Short-term investments	716,995)	358,972)	381,075)	188,679)	156,475)
Accounts receivable	147)	51,819)	4,420)	5,163)	2,231)
Contract assets	—)	—)	—)	—)	4,554)
Prepaid expenses and other current assets	12,462)	12,215)	5,741)	3,477)	2,158)
Current assets	795,186)	535,672)	474,221)	233,752)	207,674)
Long-term investments	46,708)	152,050)	36,954)	42,650)	—)
Property and equipment, net	80,453)	73,271)	13,346)	4,530)	3,204)
Operating lease right-of-use assets	82,737)	73,138)	2,924)	—)	—)
Other assets	9,691)	7,188)	6,358)	8,882)	300)
Non-current assets	219,589)	305,647)	59,582)	56,062)	3,504)
Total assets	1,014,775)	841,319)	533,803)	289,814)	211,178)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Total assets exhibited a consistent and significant upward trajectory between 2018 and 2022, increasing from 211.18 million to 1.01 billion. This growth is primarily driven by an expansion in current assets and a substantial increase in non-current operational infrastructure.

Liquidity and Cash Management: Current assets grew from 207.67 million in 2018 to 795.19 million in 2022. A dominant portion of this increase is attributed to short-term investments, which surged from 156.48 million to 716.99 million over the period. While cash and cash equivalents peaked in 2021 at 112.67 million, the 2022 data shows a reallocation toward short-term investments, suggesting a strategy focused on maximizing returns on idle capital while maintaining high liquidity.
Operational Infrastructure and Long-Term Assets: Non-current assets saw a dramatic increase from 3.50 million in 2018 to 219.59 million in 2022. This trend is characterized by the growth of property and equipment, net, which rose from 3.20 million to 80.45 million. Additionally, operating lease right-of-use assets were introduced in 2020 and expanded rapidly to 82.74 million by 2022, indicating a significant increase in leased operational capacity and physical footprint.
Working Capital Fluctuations: Accounts receivable remained relatively low for most of the period but experienced a sharp, anomalous spike to 51.82 million in 2021 before dropping to 147 thousand in 2022. This suggests a temporary accumulation of receivables that were subsequently settled. Prepaid expenses and other current assets also showed a steady upward trend, increasing from 2.16 million to 12.46 million.
Investment Strategy: Long-term investments displayed notable volatility, peaking at 152.05 million in 2021 before declining to 46.71 million in 2022. This fluctuation, when viewed alongside the massive increase in short-term investments, indicates a strategic shift toward shorter-duration assets and enhanced capital flexibility.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?